The 3 analysts offering 12-month price forecasts for ANI Pharmaceuticals Inc have a median target of 40.00, with a high estimate of 45.00 and a low estimate of 30.00. The median estimate represents a +23.27% increase from the last price of 32.45.
The current consensus among 3 polled investment analysts is to Buy stock in ANI Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.89
Reporting Date Nov 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.